Literature DB >> 18826477

TLR- and CXCR1-dependent innate immunity: insights into the genetics of urinary tract infections.

B Ragnarsdóttir1, H Fischer, G Godaly, J Grönberg-Hernandez, M Gustafsson, D Karpman, A C Lundstedt, N Lutay, S Rämisch, M L Svensson, B Wullt, M Yadav, C Svanborg.   

Abstract

The susceptibility to urinary tract infection (UTI) is controlled by the innate immune response and Toll like receptors (TLRs) are the sentinels of this response. If productive, TLR4 signalling may initiate the symptomatic disease process. In the absence of TLR4 signalling the infected host instead develops an asymptomatic carrier state. The activation of mucosal TLR4 is also influenced by the properties of the infecting strain, and pathogens use their virulence factors to trigger 'pathogen-specific' TLR4 responses in the urinary tract but do not respond to the asymptomatic carrier strains in patients with asymptomatic bacteriuria (ABU). The TLR4 dependence has been demonstrated in mice and the relevance of low TLR4 function for protection for human disease was recently confirmed in children with asymptomatic bacteriuria, who expressed less TLR4 than age matched controls. Functional chemokines and functional chemokine receptors are crucial for neutrophil recruitment, and for the neutrophil dependent bacterial clearance. Interleukin (IL)-8 receptor deficient mice develop acute septic infections and chronic tissue damage, due to aberrant neutrophil function. This mechanism is relevant for human UTI as pyelonephritis prone children express low levels of the human CXCL8 (Il-8) receptor, CXC chemokine receptor 1 (CXCR1) and often have heterozygous CXCR1 polymorphisms. This review illustrates how intimately the innate response and the susceptibility to UTI are linked and sophisticated recognition mechanisms that rely on microbial virulence and on host TLR4 and CXCR1 signalling.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18826477     DOI: 10.1111/j.1365-2362.2008.02004.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  33 in total

Review 1.  Asymptomatic bacteriuria: when the treatment is worse than the disease.

Authors:  Barbara W Trautner
Journal:  Nat Rev Urol       Date:  2011-12-06       Impact factor: 14.432

Review 2.  Host-pathogen interactions in urinary tract infection.

Authors:  Greta R Nielubowicz; Harry L T Mobley
Journal:  Nat Rev Urol       Date:  2010-07-20       Impact factor: 14.432

3.  Molecular analysis of asymptomatic bacteriuria Escherichia coli strain VR50 reveals adaptation to the urinary tract by gene acquisition.

Authors:  Scott A Beatson; Nouri L Ben Zakour; Makrina Totsika; Brian M Forde; Rebecca E Watts; Amanda N Mabbett; Jan M Szubert; Sohinee Sarkar; Minh-Duy Phan; Kate M Peters; Nicola K Petty; Nabil-Fareed Alikhan; Mitchell J Sullivan; Jayde A Gawthorne; Mitchell Stanton-Cook; Nguyen Thi Khanh Nhu; Teik Min Chong; Wai-Fong Yin; Kok-Gan Chan; Viktoria Hancock; David W Ussery; Glen C Ulett; Mark A Schembri
Journal:  Infect Immun       Date:  2015-02-09       Impact factor: 3.441

Review 4.  Genetics of innate immunity and UTI susceptibility.

Authors:  Bryndís Ragnarsdóttir; Nataliya Lutay; Jenny Grönberg-Hernandez; Bela Köves; Catharina Svanborg
Journal:  Nat Rev Urol       Date:  2011-07-12       Impact factor: 14.432

5.  Genome-wide mapping of cystitis due to Streptococcus agalactiae and Escherichia coli in mice identifies a unique bladder transcriptome that signifies pathogen-specific antimicrobial defense against urinary tract infection.

Authors:  Chee K Tan; Alison J Carey; Xiangqin Cui; Richard I Webb; Deepak Ipe; Michael Crowley; Allan W Cripps; William H Benjamin; Kimberly B Ulett; Mark A Schembri; Glen C Ulett
Journal:  Infect Immun       Date:  2012-06-25       Impact factor: 3.441

6.  Bactofection with toll-like receptor 4 in a murine model of urinary tract infection.

Authors:  Lubomíra Tóthová; Július Hodosy; Natália Kamodyová; Pavol Janega; Lívia Slobodníková; Adriana Liptáková; Peter Boor; Peter Celec
Journal:  Curr Microbiol       Date:  2011-03-27       Impact factor: 2.188

7.  The innate immune response to uropathogenic Escherichia coli involves IL-17A in a murine model of urinary tract infection.

Authors:  Kelsey E Sivick; Matthew A Schaller; Sara N Smith; Harry L T Mobley
Journal:  J Immunol       Date:  2010-01-18       Impact factor: 5.422

8.  Pathogen specific, IRF3-dependent signaling and innate resistance to human kidney infection.

Authors:  Hans Fischer; Nataliya Lutay; Bryndís Ragnarsdóttir; Manisha Yadav; Klas Jönsson; Alexander Urbano; Ahmed Al Hadad; Sebastian Rämisch; Petter Storm; Ulrich Dobrindt; Ellaine Salvador; Diana Karpman; Ulf Jodal; Catharina Svanborg
Journal:  PLoS Pathog       Date:  2010-09-23       Impact factor: 6.823

Review 9.  Genetic risk for recurrent urinary tract infections in humans: a systematic review.

Authors:  M Zaffanello; G Malerba; L Cataldi; F Antoniazzi; M Franchini; E Monti; V Fanos
Journal:  J Biomed Biotechnol       Date:  2010-03-30

10.  Use of zebrafish to probe the divergent virulence potentials and toxin requirements of extraintestinal pathogenic Escherichia coli.

Authors:  Travis J Wiles; Jean M Bower; Michael J Redd; Matthew A Mulvey
Journal:  PLoS Pathog       Date:  2009-12-18       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.